Specific α4β2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkey

Synapse

Volumn 65, Issue 12, 2011, Pages 1309-1318

  Hillmer, A T ^a,b   Wooten, D W ^a,b   Moirano, J M ^a,b   Slesarev, M ^b,c   Barnhart, T E ^a   Engle, J W ^a   Nickles, R J ^a   Murali, D ^a,b   Schneider, M L ^b,c   Mukherjee, J ^d   Christian, B T ^a,b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Nicotinic acetylcholine receptors; Nifene; PET

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR ALPHA4BETA2; NIFENE F 18; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BOLUS INJECTION; BRAIN REGION; CEREBELLUM; CINGULATE GYRUS; CORPUS STRIATUM; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; DRUG UPTAKE; FEMALE; FRONTAL CORTEX; INSULA; LATERAL GENICULATE NUCLEUS; MALE; MESENCEPHALON; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHESUS MONKEY; SUBICULUM; TEMPORAL CORTEX; THALAMUS;

ANIMALS; BINDING SITES; BRAIN; FEMALE; MACACA MULATTA; MALE; NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; PYRIDINES; PYRROLES; RECEPTORS, NICOTINIC;

EID: 80053908606     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20965     Document Type: Article

References (39)

1. Brody AL, Mandelkern MA, London ED, Olmstead RE, Farahi J, Scheibal BA, Jou J, Allen V, Tiongson E, Chefer S, Koren A, Mukhin AG. 2006. Cigarette smoking saturates brain α4β2 nicotinic acetylcholine receptors. Arch Gen Psychiat 63: 907-915.
2. Chefer SI, London ED, Koren AO, Pavlova OA, Kurian V, Kimes AS, Horti AG, Mukhin AG. 2003. Graphical analysis of 2-[18-F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain. Synapse 48: 25-34.
3. Chefer SI, Pavlova OA, Zhang Y, Vaupel DB, Kimes AS, Horti AG, Stein E, Mukhin AG. 2008. NIDA522131, a new radioligand for imaging extrathalamic nicotinic acetylcholine receptors: In vitro and in vivo evaluation. J Neurochem 104: 306-315.
4. Christian BT, Vandehey NT, Floberg JM, Mistretta CA. 2010. Dynamic PET denoising with HYPR processing. J Nucl Med 51: 1147-1154.
5. Cimino M, Marini P, Fornasari D, Cattabeni F, Clementi F. 1992. Distribution of nicotinic acetylcholine receptors in cynomolgus monkey brain and ganglia: Localization of alpha 3 subunit mRNA, alpha-bungarotoxin and nicotine binding sites. Neuroscience 51: 77-86.
6. Easwaramoorthy B, Pichika R, Collins D, Potkin SG, Leslie FM, Mukherjee J. 2007. Effect of acetylcholinesterase inhibitors on the binding of nicotinic a4b2 receptor PET radiotracer, 18 F-nifene: A measure of acetylcholine competition. Synapse 36: 29-36.
7. Easwaramoorthy B, Pichika R, Constantinescu C, Saigal N, Coleman R, Mukherjee J. 2008. Measurement of brain and plasma metabolites of 18F-Nifene. J Nucl Med 49: 142P.
8. 18F]Fluoro-A-85380. Synapse 63: 752-763.
9. Gallezot J-D, Bottlaender MA, Delforge J, Valette H, Saba W, Dolle F, Coulon CM, Ottaviani MP, Hinnen F, Syrota A, Gregoire M-C. 2008. Quantification of cerebral nicotinic acetylcholine receptors by PET using 2-[18F]fluoro-A-85380 and the multiinjection approach. J Cereb Blood Flow Metab 28: 172-189.
10. Gotti C, Clementi F. 2004. Neuronal nicotinic receptors: From structure to pathology. Prog Neurobiol 74: 363-396.
11. 125I]α-bungarotoxin binding sites in the brain of Macaca mulatta. J Comp Neurol 461: 49-60.
12. Hogg RC, Raggenbass M, Bertrand D. 2003. Nicotinic acetylcholine receptors: From structure to brain function. Rev Physiol Biochem P 147: 1-46.
13. Horti AG, Gao Y, Kuwabara H, Dannals RF. 2010. Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography. Life Sci 86: 575-584.
14. Hukkanen J, Iii PJ, Benowitz NL. 2005. Metabolism and disposition kinetics of nicotine. Pharmacology 57: 79-115.
15. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang S-C, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Silfstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE. 2007. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27: 1533-1539.
16. Jenkinson M, Bannister P, Brady M, Smith S. 2002. Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage 17: 825-841.
17. 18F]F-A85380. NeuroImage 39: 717-727.
18. * Nicotinic receptor populations in monkey striatum after nigrostriatal damage. J Pharmacol Exp Ther 303: 633-639.
19. 18F-Fluoro-A-85380. J Nucl Med 48: 1492-1500.
20. Leonard S, Breese C, Adams C, Benhammou K, Gault J, Stevens K, Lee M, Adler L, Olincy A, Ross R, Freedman R. 2000. Smoking and schizophrenia: Abnormal nicotinic receptor expression. Eur J Pharmacol 393: 237-242.
21. Logan J, Fowler JS, Volkow D, Wang GJ, Ding YS, Alexoff DL. 1996. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16: 834-840.
22. 3H]epibatidine. Brain Res 801: 143-149.
23. Matta SG et al. 2007. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology 190: 269-319.
24. *-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease. Arch Gen Psychiat 66: 866-877.
25. Mitkovski S, Villemagne VL, Novakovic KE, O'Keefe G, Tochon-Danguy H, Mulligan RS, Dickinson KL, Saunder T, Gregoire MC, Bottlaender M, Dolle F, Rowe CC. 2005. Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET. Nucl Med Biol 32: 585-591.
26. Mukhin AG, Kimes AS, Chefer SI, Matochik JA, Contoreggi CS, Horti AG, Vaupel DB, Pavlova O, Stein E. 2008. Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: A PET study with 2-18F-FA-85380. J Nucl Med 49: 1628-1635.
27. Paterson D, Nordberg A. 2000. Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61: 75-111.
28. Paxinos G, Huang XF, Toga AW. 2000. The rhesus monkey brain. New York: Academic Press.
29. Perry E, Walker M, Grace J, Perry R. 1999. Acetylcholine in mind: A neurotransmitter correlate of consciousness? Trends Neurosci 22: 273-280.
30. Picard F, Bruel D, Servent D, Saba W, Fruchart-Gaillard C, Schollhorn-Peyronneau MA, Roumenov D, Brodtkorb E, Zuberi S, Gambardella A, Steinborn B, Hufnagel A, Valette H, Bottlaender M. 2006. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: A PET study. Brain 129: 2047-2060.
31. 18F-nifene) in rodents and imaging by PET in nonhuman primate. Nucl Med Biol 33: 295-304.
32. Sabri O, Kendziorra K, Wolf H, Gertz HJ, Brust P. 2008. Acetylcholine receptors in dementia and mild cognitive impairment. Eur J Nucl Med Mol I 35: S30-S45.
33. Sacco KA, Bannon KL, George TP. 2004. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol 18: 457-474.
34. * subtype in the modulation of dopamine release from rat striatal synaptosomes. J Neurosci 20: 2783-2791.
35. Sihver W, Nordberg A, Långström B, Mukhin AG, Koren AO, Kimes AS, London ED. 2000. Development of ligands for in vivo imaging of cerebral nicotinic receptors. Behav Brain Res 113: 143-157.
36. Tai YC, Chatziioannou A, Siegel S, Young J, Newport D, Goble RN, Nutt RE, Cherry SR. 2001. Performance evaluation of the microPET P4: A PET system dedicated to animal imaging. Phys Med Biol 46: 1856-1862.
37. 18F]Fluoro-A-85380. J Nucl Med 40: 1374-1380.
38. Valette H, Bottlaender M, Dollé F, Coulon C, Ottaviani, Syrota A. 2003. Long-lasting occupancy of central nicotinic acetylcholine receptors after smoking: A PET study in monkeys. J Neurochem 84: 105-111.
39. Villemagne VL, Horti A, Scheffel U, Ravert HT, Finley P, Clough DJ, London ED, Wagner HN, Dannals RF. 1997. Imaging Nicotinic Actylcholine Receptors with Fluorine-18-FPH, and Epibatidine Analog. J Nucl Med 38: 1737-1741.